The results showed the inhibition of UCPH-101 and the deficiency of SLC1A3 both impaired the viability of PAAD cell line BxPC3 (Fig. 1M; Fig. S8, 9). This evidence concerns the gene SLC1A3 and pancreatic adenocarcinoma.